West Pharmaceutical Services
West Pharmaceutical Services, Inc., commonly referred to as West, is a leading provider of innovative solutions for injectable drug delivery and containment. Headquartered in the United States, West operates extensively across major regions, including Europe and Asia, serving a global clientele in the pharmaceutical and biotechnology industries. Founded in 1923, the company has achieved significant milestones, including advancements in drug delivery systems and the development of high-quality packaging solutions. West's core offerings include a range of primary packaging components, delivery systems, and contract manufacturing services, all designed to enhance the safety and efficacy of medications. What sets West apart is its commitment to quality and innovation, ensuring that its products meet the stringent demands of the healthcare sector. With a strong market position and a reputation for excellence, West continues to be a trusted partner for pharmaceutical companies worldwide.
DitchCarbon Score
How does West Pharmaceutical Services's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
West Pharmaceutical Services's score of 38 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
West Pharmaceutical Services's reported carbon emissions
In 2023, West Pharmaceutical Services reported total emissions of approximately 104,190,000 kg CO2e, encompassing Scope 1 and Scope 2 emissions. This figure reflects the company's ongoing commitment to reducing its carbon footprint. West Pharmaceutical Services has set ambitious targets to reduce absolute emissions by 40% across both Scope 1 and Scope 2 by 2030, starting from 2022. Additionally, the company aims to achieve 50% renewable electricity usage and improve energy efficiency by 3% year-over-year within the same timeframe. In previous years, the company reported significant emissions, including approximately 128,234,000 kg CO2e in 2021, with Scope 1 emissions at about 31,310,000 kg CO2e and Scope 2 emissions at approximately 105,689,000 kg CO2e. The 2020 emissions were similarly substantial, totalling around 120,858,000 kg CO2e, with Scope 1 and Scope 2 emissions contributing approximately 28,495,000 kg CO2e and 117,996,000 kg CO2e, respectively. West Pharmaceutical Services is committed to enhancing its sustainability practices and addressing climate change through these reduction initiatives, positioning itself as a responsible player in the pharmaceuticals and biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 28,699,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - |
| Scope 2 | 118,243,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - |
| Scope 3 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
West Pharmaceutical Services is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
